Literature DB >> 9153221

Interferon-gamma increases the sensitivity of islets of Langerhans for inducible nitric-oxide synthase expression induced by interleukin 1.

M R Heitmeier1, A L Scarim, J A Corbett.   

Abstract

The purpose of this study was to evaluate the effects of interferon-gamma (IFN-gamma) alone and in combination with interleukin 1beta (IL-1beta) on inducible nitric-oxide synthase (iNOS) mRNA and protein expression, nitrite production, and insulin secretion by islets of Langerhans. Treatment of rat islets with IL-1beta results in a concentration-dependent increase in the production of nitrite that is maximal at 5 units/ml. Individually, 0. 1 unit/ml IL-1beta or 150 units/ml rat IFN-gamma do not stimulate iNOS expression or nitrite production by rat islets; however, in combination, these cytokines induce the expression of iNOS and the production of nitrite to levels similar in magnitude to the individual effects of 5 units/ml IL-1beta. The islet beta-cell, selectively destroyed during insulin-dependent diabetes mellitus, appears to be one islet cellular source of iNOS as 150 units/ml rat IFN-gamma and 0.1 unit/ml IL-1beta induced similar effects in primary beta-cells purified by fluorescence-activated cell sorting and in the rat insulinoma cell line, RINm5F. iNOS expression and nitrite production by rat islets in response to 150 units/ml rat IFN-gamma and 0.1 unit/ml IL-1beta are correlated with an inhibition of insulin secretion and islet degeneration that are prevented by the iNOS inhibitor aminoguanidine. The mechanism by which IFN-gamma increases the sensitivity of beta-cells for IL-1-induced iNOS expression appears to be associated with an increase in the stability of iNOS mRNA. Last, cellular damage during physical dispersion of islets results in the release of sufficient amounts of IL-1beta to induce iNOS expression and nitrite production in the presence of exogenously added rat IFN-gamma. The cellular source of IL-1beta under these conditions is believed to be resident islet macrophages as depletion of macrophages prior to dispersion prevents IFN-gamma-induced iNOS expression and nitrite formation by dispersed islet cells. These studies show that the T-lymphocyte cytokine, IFN-gamma, increases the sensitivity of rat islets to the effects of IL-1beta on iNOS expression and nitrite production by 10-fold, in part, through the stabilization of iNOS mRNA. Our studies also support an effector role for IFN-gamma, in concert with resident islet macrophage release of IL-1beta, in mediating beta-cell destruction during the development of autoimmune diabetes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9153221     DOI: 10.1074/jbc.272.21.13697

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

Review 1.  Effector lymphocytes in islet cell autoimmunity.

Authors:  Pere Santamaria
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

2.  FoxO1 and SIRT1 regulate beta-cell responses to nitric oxide.

Authors:  Katherine J Hughes; Gordon P Meares; Polly A Hansen; John A Corbett
Journal:  J Biol Chem       Date:  2011-01-01       Impact factor: 5.157

3.  Ccr5 regulates inflammatory gene expression in response to encephalomyocarditis virus infection.

Authors:  Benjamin S Christmann; Jason M Moran; Jennifer A McGraw; R Mark L Buller; John A Corbett
Journal:  Am J Pathol       Date:  2011-10-11       Impact factor: 4.307

4.  Cytokine-mediated β-cell damage in PARP-1-deficient islets.

Authors:  Teresa Andreone; Gordon P Meares; Katherine J Hughes; Polly A Hansen; John A Corbett
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-04-24       Impact factor: 4.310

5.  Mechanisms of beta-cell death in response to double-stranded (ds) RNA and interferon-gamma: dsRNA-dependent protein kinase apoptosis and nitric oxide-dependent necrosis.

Authors:  A L Scarim; M Arnush; L A Blair; J Concepcion; M R Heitmeier; D Scheuner; R J Kaufman; J Ryerse; R M Buller; J A Corbett
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

6.  IFN-gamma-dependent regulatory circuits in immune inflammation highlighted in diabetes.

Authors:  Boris Calderon; Anish Suri; Xiaoou O Pan; Jason C Mills; Emil R Unanue
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

7.  NF-κB and STAT1 control CXCL1 and CXCL2 gene transcription.

Authors:  Susan J Burke; Danhong Lu; Tim E Sparer; Thomas Masi; Matthew R Goff; Michael D Karlstad; J Jason Collier
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-11-26       Impact factor: 4.310

Review 8.  Pancreatic islet inflammation: an emerging role for chemokines.

Authors:  J Jason Collier; Tim E Sparer; Michael D Karlstad; Susan J Burke
Journal:  J Mol Endocrinol       Date:  2017-04-18       Impact factor: 5.098

Review 9.  Epigenetics: the missing link to understanding β-cell dysfunction in the pathogenesis of type 2 diabetes.

Authors:  Elizabeth R Gilbert; Dongmin Liu
Journal:  Epigenetics       Date:  2012-07-19       Impact factor: 4.528

10.  Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway.

Authors:  Ji-Hyun Lee; Mi-Young Song; Eun-Kyung Song; Eun-Kyung Kim; Woo Sung Moon; Myung-Kwan Han; Jin-Woo Park; Kang-Beom Kwon; Byung-Hyun Park
Journal:  Diabetes       Date:  2008-11-13       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.